Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2025-12-25 @ 5:20 PM
NCT ID: NCT00611403
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00611403
Study Brief: Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
RESTASIS® Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) None None 1 68 16 68 View
REFRESH ENDURA® Artificial Tears (REFRESH ENDURA®) None None 1 69 8 69 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Colon cancer stage IV SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (11.1) View
Infected bites NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Seasonal allergy NON_SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA (11.1) View